...
首页> 外文期刊>Dalton transactions: An international journal of inorganic chemistry >The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities
【24h】

The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities

机译:钒与1,2-二羟基蒽醌配合物的合成,表征及其体外抗癌活性的结构效应关系

获取原文
获取原文并翻译 | 示例
           

摘要

[V~VO_2(O_2C_(14)H_6O _2)(C_5N_2H_(12))](C_5N _2H_(13))(CH_3OH) (1) and {Na[V~VO(O _2C_(14)H_6O_2)_2][(CH _3)_2NCHO]}_n (2) have been synthesized by the reaction of V_2O_5 and NaVO_3 with aromatic 1,2-diol (1,2-dihydroxyanthraquinone), and their molecular and crystal structures have been determined by X-ray diffraction. MTT assay tests of the V~VO_2L_AL_B and V~VOL _2 complexes against cancer cells have revealed that, when L is catechol, VOL_2 showed broad-spectrum, high anticancer activities which were proportional to their concentration; however when L is naphthol or alizarin, VOL_2 displayed little effect towards the cancer cells; moreover, complex 1 in the coordination model of V~VO _2L_AL_B showed specifically higher inhibition (88.65%) against HCT-8 than the clinical anticancer drug Fu-5 (69.97%). The results revealed that both the V(v) and the ligands cannot influence the inhibition against cancer cells individually. The mechanism of the broad-spectrum anticancer activities of VOL_2 when L is catechol ligand might originate from the redox activities of V~V/V~(IV) which regulate the concentration of ROS (reactive oxygen species). N-Methylpiperazine formed as a by-product in complex 1 was confirmed by ~1H NMR and its formation mechanism catalyzed by V_2O _5 has been deduced.
机译:[V〜VO_2(O_2C_(14)H_6O _2)(C_5N_2H_(12))] [C_5N _2H_(13))(CH_3OH)(1)和{Na [V〜VO(O _2C_(14)H_6O_2)_2] [ (CH _3)_2NCHO]} _ n(2)是通过V_2O_5和NaVO_3与芳香族1,2-二醇(1,2-二羟基蒽醌)的反应合成的,其分子和晶体结构已通过X射线衍射确定。对癌细胞的V〜VO_2L_AL_B和V〜VOL_2复合物的MTT分析测试表明,当L为儿茶酚时,VOL_2表现出广谱,高抗癌活性,与它们的浓度成正比。然而,当L为萘酚或茜素时,VOL_2对癌细胞的作用很小;此外,V〜VO _2L_AL_B协调模型中的复合物1对HCT-8的抑制作用(88.65%)比临床抗癌药物Fu-5的抑制作用(69.97%)特别高。结果表明,V(v)和配体都不能单独影响对癌细胞的抑制作用。当L为邻苯二酚配体时,VOL_2的广谱抗癌机制可能源于V〜V / V〜(IV)的氧化还原活性,其调节ROS的浓度。通过〜1H NMR证实了配合物1中作为副产物形成的N-甲基哌嗪,并推导了其被V_2O _5催化的形成机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号